Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
about
DLC-1: a Rho GTPase-activating protein and tumour suppressorImpact of protein kinase PKR in cell biology: from antiviral to antiproliferative actionInhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell linesRole of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motilityKLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions.Chemogenomics approaches to novel target discovery.Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancerDeleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinomaActivating transcription factor 3 promotes malignance of lung cancer cells in vitroActivating transcription factor 3 promotes embryo attachment via up-regulation of leukemia inhibitory factor in vitro.Anti-inflammatory and anti-cancer activity of mulberry (Morus alba L.) root barkMetformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.NME2 reduces proliferation, migration and invasion of gastric cancer cells to limit metastasisATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p.Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs.Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation.Role of endocrine and growth factors on the ovarian surface epithelium.ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.Hormone response in ovarian cancer: time to reconsider as a clinical target?Caveolin-1: an ambiguous partner in cell signalling and cancer.Upregulation of ATF-3 is correlated with prognosis and proliferation of laryngeal cancer by regulating Cyclin D1 expression.Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.ATF3 transcription factor and its emerging roles in immunity and cancerNestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathwayActivating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.Regulation of the metastasis suppressor Nm23-H1 by tumor viruses.Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.Activating transcription factor 3 regulates survivability and migration of vascular smooth muscle cells.Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine.Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types.
P2860
Q23917637-3C816CC8-E910-44A4-A7ED-257456E2F2AFQ24672548-807DA3CE-238E-4B85-A241-9C7DDFCC321AQ24678585-2CC114ED-0392-4BA2-80CC-D3D433594C39Q28391398-4C83AE8D-876D-45CA-9A48-42437B8F05BFQ28771723-01D6263E-BCD0-4F44-87B4-C678B8CEBCF9Q30447293-C34D0CB7-4AD9-4F2D-9E5F-994459B6C960Q30494435-8BCFF6EA-3B8E-499E-AF4D-C78CA8B19F5CQ33286936-696FAF65-F9A5-4FAD-BE70-6423EF531DA9Q33309499-B977DC6B-2EE7-41BE-8F19-A4A1E09A037AQ33354161-FEBB95EE-1ABF-4EB8-A621-C5F835DE640BQ33633724-363D4BF8-5575-48FF-840D-AAC225A64615Q33759428-B75EDAC4-D2DB-4D0A-9C97-2A7F1DBAB9AEQ33818236-4F7711ED-9307-46D4-BD9D-B72BD85FBCECQ33914014-97E3C380-6E6D-4106-9445-528BEDB7040EQ34009832-A7209A5A-5560-4DA5-B123-58BE885740A4Q34200707-BA076D40-7D3A-4E5F-95F0-D6B916263DBAQ34463814-FAB5CDB5-7655-42E0-BABE-ED4B102FE603Q34483678-71B8D730-4C3F-4DE3-BD16-0A32523A396AQ34764768-AB0750BF-E210-4D12-9556-796AF46DAC64Q35048067-0DBACDFB-0A90-4587-B4B3-47E7EC2441C8Q35791587-25B88F93-ADD0-469F-B16E-33B405BE25E2Q36175366-D22DABE2-654B-4C21-A43E-E9830397A82FQ36672324-A99C6756-170A-4468-8B20-EE491BD0D8DBQ36703049-73C16C18-B8CB-46F4-8506-1BF7CA7D2FF0Q36774904-0F681172-AFF8-40F9-8019-D09F8B633B4BQ36798094-54C7FEEA-4E89-4959-83E8-FAB81B03FCB3Q36966197-7F6AF55B-32C9-461D-AB8B-28DE2C86DB7EQ37133373-11F29D64-5F02-4805-BD6B-5A7A1E833FE3Q37228820-082659E8-B155-4615-BBA7-2D44181A2562Q37295559-361FDB89-F6A0-40B2-8F42-B4355DA59324Q37439129-540C5F39-D37E-4277-8CED-7E6B65E56F16Q37688433-A0CB6EEC-B681-44D7-BC11-DBF8AB962C34Q37706969-6F378AEF-DB4B-45E8-9F3F-D14683DCB504Q38246971-BFE6F6DF-D368-4015-819A-C89B6BD6310DQ38270093-53BBEC87-B9E1-4597-8A66-D7B84AC95F8AQ38321797-61340B0F-67E4-469F-A4FF-5564E6232A98Q38337687-5879939F-54A2-4B26-83C2-A4E0734EC6C7Q39023830-1FD85AB5-42BB-4A02-9EFE-2D0E01CA86F8Q39320426-3F7662BA-91DE-41FB-882E-52E2F3CBBAF0Q39545397-9A9DC731-D1AA-4903-A341-ECB780FA6269
P2860
Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@ast
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@en
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@nl
type
label
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@ast
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@en
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@nl
prefLabel
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@ast
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@en
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@nl
P2093
P2860
P3181
P356
P1433
P1476
Identification of ATF-3, caveo ...... cancer cells by gene profiling
@en
P2093
James Lyons-Weiler
Kasturi Mukherjee
Kin-Mang Lau
Shuk-mei Ho
Takashi Tsuruo
Tetsuo Mashima
Viqar Syed
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1207991
P407
P577
2005-03-03T00:00:00Z
P5875
P6179
1050673481